CIANFARANI, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 40.489
AS - Asia 6.914
EU - Europa 4.421
SA - Sud America 864
AF - Africa 96
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 6
Totale 52.815
Nazione #
US - Stati Uniti d'America 40.271
SG - Singapore 3.689
CN - Cina 1.381
IT - Italia 1.037
BR - Brasile 726
RU - Federazione Russa 598
UA - Ucraina 549
DE - Germania 518
HK - Hong Kong 486
VN - Vietnam 459
IE - Irlanda 382
FR - Francia 339
FI - Finlandia 248
GB - Regno Unito 244
BD - Bangladesh 231
JP - Giappone 152
PL - Polonia 147
CA - Canada 136
KR - Corea 130
SE - Svezia 126
IN - India 87
NL - Olanda 78
AR - Argentina 57
ID - Indonesia 56
MX - Messico 44
TR - Turchia 41
ES - Italia 39
IQ - Iraq 39
ZA - Sudafrica 31
AU - Australia 21
BE - Belgio 21
EC - Ecuador 21
AT - Austria 19
PK - Pakistan 19
PH - Filippine 17
CO - Colombia 16
MY - Malesia 15
SA - Arabia Saudita 15
IR - Iran 12
MA - Marocco 12
TH - Thailandia 11
VE - Venezuela 11
CL - Cile 10
JM - Giamaica 10
RO - Romania 10
UZ - Uzbekistan 10
DZ - Algeria 9
JO - Giordania 9
LT - Lituania 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
KE - Kenya 8
PY - Paraguay 8
AL - Albania 7
CH - Svizzera 7
CR - Costa Rica 7
PE - Perù 7
BG - Bulgaria 6
EU - Europa 6
IL - Israele 6
AO - Angola 5
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
EG - Egitto 5
NP - Nepal 5
OM - Oman 5
PT - Portogallo 5
SN - Senegal 5
TW - Taiwan 5
BO - Bolivia 4
ET - Etiopia 4
GT - Guatemala 4
HU - Ungheria 4
AM - Armenia 3
CI - Costa d'Avorio 3
GR - Grecia 3
KZ - Kazakistan 3
NO - Norvegia 3
PA - Panama 3
RS - Serbia 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
KG - Kirghizistan 2
KW - Kuwait 2
MD - Moldavia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SC - Seychelles 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BZ - Belize 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
Totale 52.795
Città #
Woodbridge 11.378
Wilmington 10.034
Houston 8.967
Singapore 1.295
Fairfield 1.120
Ashburn 890
San Jose 679
Ann Arbor 667
Chandler 565
Jacksonville 485
Hong Kong 477
Seattle 474
Beijing 464
Cambridge 390
Dublin 378
Medford 300
New York 263
Santa Clara 262
The Dalles 207
Council Bluffs 200
Los Angeles 184
Rome 174
Ho Chi Minh City 149
Lawrence 135
Tokyo 129
Dearborn 127
Helsinki 118
Buffalo 109
Kraków 102
Hanoi 99
Moscow 90
Lauterbourg 89
Shanghai 88
Milan 86
San Diego 81
Suzhou 71
Dallas 67
São Paulo 64
Mülheim 60
Orem 54
London 46
Menlo Park 44
Chicago 40
Munich 40
Warsaw 39
Jakarta 37
Nuremberg 34
Creede 33
Toronto 33
Atlanta 31
Montreal 30
North Bergen 29
Naples 28
Verona 28
Denver 27
Phoenix 27
Boardman 26
Falls Church 26
Redondo Beach 26
Detroit 25
Brooklyn 24
University Park 24
Palermo 23
Florence 22
San Francisco 22
Turin 22
Brussels 20
Guangzhou 20
Johannesburg 20
Haiphong 19
Manchester 19
Nanjing 19
Seoul 19
Chennai 18
Da Nang 18
Frankfurt am Main 18
Stockholm 18
Zhengzhou 18
Belo Horizonte 17
Dong Ket 17
Norwalk 17
Poplar 17
Redwood City 17
Amsterdam 16
Mexico City 16
Rio de Janeiro 16
Curitiba 15
Monte Vista 15
Mountain View 15
Turku 15
Ankara 14
Hefei 14
Vancouver 14
Brasília 13
Hangzhou 13
Mumbai 13
Shenyang 13
Baghdad 12
Chongqing 12
Dhaka 12
Totale 42.906
Nome #
Diabete insipido e sindrome da inappropriata secrezione di ormone antidiurerico “Diabetes insipidus and sindrome of inappropriate antidiuretic hormone SIADH”. 722
Management of the child born small for gestational age through to adulthood: A consensus statement of the international societies of pediatric endocrinology and the Growth Hormone Research Society 698
Tall stature in familial glucocorticoid deficiency 598
Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: pathogenetic role of genetic background and intrauterine environment 579
Isolation and characterization of omental adipose progenitor cells in children: a potential tool to unravel the pathogenesis of metabolic syndrome. 571
Postnatal onset of severe growth retardation after in utero exposure to carbamazepine and phenobarbital: a case report 551
FGF17, a gene involved in cerebellar development, is downregulated in a patient with Dandy-Walker malformation carrying a de novo 8p deletion 535
A new case of Ambras syndrome associated with a paracentric inversion (8) (q12; q22) 522
Association between growth hormone therapy and mortality, cancer and cardiovascular risk: systematic review and meta-analysis 520
Early retesting by GHRH + arginine test shows normal GH response in most children with idiopathic GH deficiency 516
Brain Magnetic Resonance Imaging as First-Line Investigation for Growth Hormone Deficiency Diagnosis in Early Childhood 511
Improving care of children with endocrine diseases 497
Adipose Tissue: a Metabolic Regulator. Potential Implications for the Metabolic Outcome of Subjects Born Small for Gestational Age (SGA). 489
Non-Alcoholic Fatty Liver Disease (NAFLD) in children and adolescents with Prader-Willi Syndrome (PWS) 489
Primary empty sella and endocrinopathies in childhood: high prevalence among children with precocious puberty 487
Catch-up growth in body mass index is associated neither with reduced insulin sensitivity nor with altered lipid profile in children born small for gestational age 486
Il ritardo dello sviluppo puberale maschile: trattamento con androgeni. 483
Adult height in children with short stature and idiopathic delayed puberty after different management. 483
IGF-I and IGFBP-3 assessment in the management of childhood onset growth hormone deficiency 473
[Treatment of somatotropic deficiency with biosynthetic growth hormone] 473
Grand Challenges in Pediatric Endocrinology 472
A position effect on TRPS1 is associated with Ambras syndrome in humans and the Koala phenotype in mice. 467
Epigenetic changes predisposing to type 2 diabetes in intrauterine growth retardation 463
Serum levels of polybrominated diphenyl ethers in girls with premature thelarche 462
Routine screening by brain magnetic resonance imaging is not indicated in every girl with onset of puberty between the ages of 6 and 8 462
Bambini Nati Piccoli per Età Gestazionale (small for gestational age, SGA): Implicazioni Cliniche. Come, Quando e Perchè Trattarli con l’Ormone della Crescita 461
Increased chromosome fragility in lymphocytes of short normal children treated with recombinant human growth hormone 460
Twelve-hour spontaneous nocturnal growth hormone secretion in growth retarded patients 457
Description of the SAGhE cohort: A large european study of mortality and cancer incidence risks after childhood treatment with recombinant growth hormone 457
Growth and insulin-like growth factors (IGFs) in children with insulin-dependent diabetes mellitus at the onset of disease: evidence for normal growth, age dependency of the IGF system alterations, and presence of a small (approximately 18-kilodalton) IGF-binding protein-3 fragment in serum 456
Marked left ventricular hypertrophy mimicking hypertrophic cardiomyopathy associated with steroid therapy for congenital adrenal hyperplasia. 453
Growth hormone therapy does not alter the insulin-like growth factor-I/insulin-like growth factor binding protein-3 molar ratio in growth hormone-deficient children 453
[Treatment with growth hormone (GH) in 3 cases of Noonan syndrome] 453
Retinol-binding protein 4 in neonates born small for gestational age 450
Adiponectin levels are reduced in children born small for gestational age and are inversely related to postnatal catch-up growth 445
Long-term safety of growth hormone therapy: still a controversial issue 445
Patologie dell’ipofisi anteriore. Deficit di GH 443
Laron dwarfism: cellular unresponsiveness to GH demonstrated on cultured lymphocytes by a cytochemical method 443
Laron dwarfism: cellular unresponsiveness to GH demonstrated on cultured lymphocytes by a cytochemical method 442
Low Birth Weight for Gestational Age Associates with Reduced Glucose Concentrations at Birth; Infancy and Childhood. 441
Hormonal regulation of postnatal growth in children born small for gestational age 441
Birth weight influences the clinical phenotype and the metabolic control of patients with type 1 diabetes (T1D) 441
Assessment of circulating levels of insulin-like growth factors in the diagnosis diagnosis of isolated childhood-onset isolated growth hormone deficiency. A proposal of the Italian Society for Pediatric Endocrinology and Diabetes. 440
Effect of intrauterine growth retardation on liver and long-term metabolic risk 439
Late Effects of Disturbed IGF Signaling in Congenital Diseases. 437
Growth and autoantibodies to IA-2 in children with type 1 diabetes 437
Laboratory tests and measurements in children born small for gestational age (SGA) 435
Inaccuracy of IGFBP-3 Assessment in the Diagnosis of Growth Hormone Deficiency (GHD) from Childhood to Young Adulthood: Association to Low GH-Dependency of IGF-II and Presence of Circulating IGFBP-3 18 kD Fragment. 434
Exposure to Uteroplacental Insufficiency Reduces the Expression of Signal Transducer and Activator of Transcription 3 and Proopiomelanocortin in the Hypothalamus of Newborn Rats 433
Insulin-like growth factor-I and -II levels are associated with the progression of nonalcoholic fatty liver disease in obese children 433
Differential ribosomal gene responsiveness to human growth hormone is visualized by selective silver staining 432
Endocrine and neuropsychological assessment in a child with a novel mutation of thyroid hormone receptor: response to 12-month triiodothyroacetic acid (TRIAC) therapy 430
Is IGF binding protein-3 assessment helpful for the diagnosis of GH deficiency? 430
Growth and growth factors 429
Impact of growth hormone therapy on adult height of children born small for gestational age. 429
Growth hormone-induced activation of rRNA gene clusters: cellular responses of normal subjects and pituitaric dwarfs 429
Growth hormone deficiency associated with pituitary abnormalities in 14q microdeletion syndrome: a new phenotype-genotype correlation? 429
Cardiovascular fitness is impaired in children born small for gestational age 426
Is high-dose growth hormone treatment during puberty Worthwhile? 422
Serum insulin-like growth factor-I (IGF-I) reference ranges for chemiluminescence assay in childhood and adolescence. Data from a population of in- and out-patients 420
Personalized Approach to Growth Hormone Treatment: Clinical Use of Growth Prediction Models 420
Conseguenze endocrine e metaboliche del bambino nato SGA 419
Consensus Statement on the Diagnosis and Treatment of Children with Idiopathic Short Stature: A Summary of the Growth Hormone Research Society; the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology Workshop 419
Review of growth hormone randomized controlled trials in children with idiopathic short stature 414
[Pretreatment growth rate and response to therapy with growth hormone (HGH)] 414
The potential role of fatty liver in paediatric metabolic syndrome: a distinct phenotype with high metabolic risk? 413
Growth retardation, delayed mental development and mild dysmorphic features in a boy with a novel interstitial deletion of chromosome 8p21.1-p12 412
Bone age assessment in the work up of children with endocrine disorders 411
Mutations within Sox2/SOX2 are associated with abnormalities in the hypothalamopituitary-gonadal axis in mice and humans 409
Insulin sensitivity in children born small for gestational age (SGA) 408
Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study 405
Growth hormone treatment and somatomedin-C levels 403
The impact of growth hormone therapy on adult height in noonan syndrome: A systematic review 400
Impact of uteroplacental insufficiency on postnatal rat male gonad 398
Uteroplacental Insufficiency Down Regulates Insulin Receptor and Affects Expression of Key Enzymes of Long-chain Fatty Acid (LCFA) Metabolism in Skeletal Muscle at Birth. 397
Central precocious puberty and cerebral magnetic resonance: when do we perform? 397
The role of androgen therapy in hypogonadal adolescent males 396
Programming, metabolic syndrome, and NAFLD: the challenge of transforming a vicious into a virtuous cycle 395
The Challenge of Growth Hormone Deficiency Diagnosis and Treatment during the Transition from Puberty into Adulthood 395
Premature Ovarian Failure associated to the Absence of Pubic and Axillary Hair in a de novo Translocation X;15 (q24;q26.3). 394
IGF2 methylation is associated with lipid profile in obese children 394
The response to gonadotropin releasing hormone (GnRH) stimulation test does not predict the progression to true precocious puberty in girls with onset of premature thelarche in the first three years of life 392
Could brain MRI replace GH stimulation tests in the work-up of GH deficiency in the first years of life? 391
Chairman's summary: Diagnostic techniques for identifying children with idiopathic short stature 386
Preterm infants with severe extrauterine growth retardation (EUGR) are at high risk of growth impairment during childhood 386
Sexual dimorphism in growth and insulin-like growth factor-I in children with type 1 diabetes mellitus 385
Precocious puberty [La pubertà precoce] 384
Responses to GHRH plus arginine test are more concordant with IGF-I circulating levels than responses to arginine and clonidine provocative tests 384
Epigenetic mechanisms elicited by nutrition in early life 378
Residual β-cell mass influences growth of prepubertal children with type 1 diabetes 377
Sensibility and Specificity of Growth Factors in GH Deficiency. 375
Neuroendocrine Complications of Central Nervous System Malformations. Chapter 23 373
Controversies in the definition and treatment of idiopathic short stature ISS. 371
Vitamin D levels and liver histological alterations in children with nonalcoholic fatty liver disease 367
Prevalence of microadenomas in children with isolated growth hormone deficiency and central precocious puberty 365
Growth hormone and treatment outcomes: expert review of current clinical practice 350
null 337
Usefulness of serum insulin-like growth factor-I (IGF-I) assessment in the diagnosis of childhood-onset GH deficiency. 333
Insulin-like growth factor-II: new roles for an old actor 329
GH safety workshop position paper: A critical appraisal of recombinant human GH therapy in children and adults 325
Totale 43.915
Categoria #
all - tutte 128.532
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 128.532


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.356 58 116 50 45 32 114 54 59 168 213 42 405
2022/20231.708 159 138 28 201 162 361 147 164 138 23 126 61
2023/2024600 76 41 41 21 58 153 28 23 14 14 34 97
2024/20255.242 102 904 457 228 114 307 212 114 321 333 1.212 938
2025/20267.736 516 374 650 639 1.041 271 888 780 867 574 534 602
2026/2027350 350 0 0 0 0 0 0 0 0 0 0 0
Totale 53.164